Aflibercept in branch retinal vein occlusion as second line therapy: clinical outcome 12 months after changing treatment from bevacizumab/ranibizumab

Aflibercept in branch retinal vein occlusion as second line therapy: clinical outcome 12 months after changing treatment from bevacizumab/ranibizumab—a pilot study

Published:2016-08-23 Issue:1 Volume:2 Page:
ISSN:2056-9920
Container-title:International Journal of Retina and Vitreous
language:en
Short-container-title:Int J Retin Vitr

Author:

Wirth Magdalena A.,Becker Matthias D.,Graf Nicole,Michels Stephan

Funder

Werner H. Spross Foundation

Publisher

Springer Science and Business Media LLC

Subject

Ophthalmology

Link

http://link.springer.com/content/pdf/10.1186/s40942-016-0045-8

Reference19 articles.

1. Klein R, Moss SE, Meuer SM, Klein BE. The 15-year cumulative incidence of retinal vein occlusion: the Beaver Dam Eye Study. Arch Ophthalmol. 2008;126(4):513–8.

2. Haymore JG, Mejico LJ. Retinal vascular occlusion syndromes. Int Ophthalmol Clin. 2009;49(3):63–79.

3. Encke A. Pathophysiology of venous thrombosis (author’s transl). Langenbecks Arch Chir. 1977;345:323–9.

4. Rehak M, Wiedemann P. Retinal vein thrombosis: pathogenesis and management. J Thromb Haemost. 2010;8(9):1886–94.

5. Deobhakta A, Chang LK. Inflammation in retinal vein occlusion. Int J Inflam. 2013;2013:438412.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Branch retinal vein occlusion treated with anti-VEGF: to switch or not to switch?;Canadian Journal of Ophthalmology;2024-02

2. Branch Retinal Vein Occlusion Treated with Anti VEGF, to Switch or not to Switch? Long Term Follow-Up;2023-03-23

3. Estimating ranibizumab injection numbers and visual acuity at 12 months based on 2-month data on branch retinal vein occlusion treatment;Scientific Reports;2022-05-10

4. Treat‐and‐extend regimens of anti‐vascular endothelial growth factor therapy for retinal vein occlusions: a systematic review and meta‐analysis;Acta Ophthalmologica;2021-11-29

5. Coats-like Exudative Vitreoretinopathy in Retinitis Pigmentosa;Ophthalmology Retina;2021-01